NFKB1 and atherosclerosis: Additionally, it was observed that endothelial-specific NF-kb inhibition protected mice from atherosclerosis development by reducing the expression of vascular adhesion molecules, cytokines and chemokines and preventing macrophage recruitment to atherosclerotic plaques, hence strongly reducing atherosclerotic plaque formation [121].